Pfizer Unit Wins $60M HHS Contract For Nerve Gas Treatment

Law360, New York (September 25, 2013, 4:00 PM EDT) -- A Pfizer Inc. subsidiary has been awarded a $60 million U.S. Department of Health and Human Services contract to study a drug that could potentially be used for seizures caused by chemical weapons, the agency said Wednesday.

Under the contract, Columbia, Md.-based Meridian Medical Technologies Inc. will seek U.S. Food and Drug Administration approval to use midazolam as a treatment of seizures caused by chemical weapons containing nerve agents, HHS said in a news release. Midazolam is currently only approved as a pre-operative sedative, HHS said. ...
To view the full article, register now.